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Abstract
Background: Physical distancing and facemask use are worldwide recognized as 
effective non- pharmaceutical interventions (NPIs) against the coronavirus disease-
 2019 (COVID- 19). Since January 2020, Taiwan has introduced both NPIs but their 
effectiveness on non- COVID- 19 respiratory viruses (NCRVs) remain underexplored.
Methods: This retrospective observational study examined electronic records at a 
tertiary hospital in northern Taiwan from pre- COVID (January– December 2019) to 
post- COVID period (January– May 2020). Patients with respiratory syndromes were 
tested for both enveloped (eg, influenza virus and seasonal coronavirus) and non- 
enveloped RVs (eg, enterovirus and rhinovirus) using multiplex reverse transcription 
polymerase chain reaction assays. Monthly positivity rates of NCRVs among adult 
and pediatric patients were analyzed with comparison between pre- and post- COVID 
periods.
Results: A total of 9693 patients underwent 12 127 multiplex RT- PCR tests. The av-
erage positivity rate of NCRVs reduced by 11.2% (25.6% to 14.4%) after nationwide 
PHIs. Despite the COVID- 19 pandemic, the most commonly identified enveloped and 
non- enveloped viruses were influenza virus and enterovirus/rhinovirus, respectively. 
Observed reduction in NCRV incidence was predominantly contributed by envel-
oped NCRVs including influenza viruses. We did not observe epidemiological impacts 
of NPIs on non- enveloped viruses but an increasing trend in enterovirus/rhinovirus 
test positivity rate among pediatric patients. Our data were validated using Taiwan's 
national notification database.
Conclusions: Our frontline investigation suggests that the current NPIs in Taiwan 
might not effectively control the transmission of non- enveloped respiratory viruses, 
despite their protective effects against influenza and seasonal coronavirus. Health 
authorities may consider using hydrogen peroxide or chloride- based disinfectants as 
additional preventative strategies against non- enveloped respiratory viruses in the 
post- COVID- 19 era.
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1  | INTRODUC TION
While the coronavirus disease- 2019 (COVID- 19) continues casting 
global health burdens, non- COVID- 19 viral respiratory tract infec-
tions (RTIs) continue devastating millions of lives with estimated 4 
million deaths worldwide.1,2 Prior to the severe acute respiratory 
syndrome coronavirus- 2 (SARS- CoV- 2), the most commonly diag-
nosed pathogenic respiratory viruses are influenza virus, parain-
fluenza virus (PIV), seasonal coronavirus (sCoV), enterovirus (EnV) 
and rhinovirus (RhV), adenovirus (AdV), human metapneumovirus 
(hMPV), and human bocavirus (hBoV). These viruses can also be vi-
rologically classified into two groups: enveloped viruses (eg, influ-
enza virus, PIV, and sCoV) and non- enveloped viruses (eg, AdV, EnV, 
and RhV). Without implementing a combination of timely testing, ac-
curate diagnosis, effective treatment, and non- pharmaceutical inter-
ventions, countries’ healthcare systems could be heavily exhausted 
by these viral RTIs compounded with the COVID- 19 pandemic.3- 6
Physical distancing and face mask use have been worldwide 
recognized as effective non- pharmaceutical interventions (NPIs) to 
mitigate the spread of COVID- 19. Mathematical models have fore-
cast that an 80% coverage of face mask use among populations can 
effectively reduce the transmission and mortality of SARS- CoV- 2 by 
17%- 45%.7 A Chinese study using real- world data reported that face 
mask use in COVID- 19 patients and their close contacts resulted in a 
79% risk reduction of SARS- CoV- 2 transmission.8 A global systematic 
review reported that face mask use and physical distancing could re-
duce risks of SARS- CoV- 2 infections by 85% and 82%, respectively.9 
Using N95 respirators among medical practitioners could reduce the 
infection rate of COVID- 19 by 95%.10 Together with contact tracing 
systems, such measures have been implemented by countries world-
wide to combat the COVID- 19 pandemic.
Taiwan, one of the countries with the lowest incidence rate 
and mortality of COVID- 19, has become an exemplar in effectively 
implementing NPIs. Following the first COVID- 19 case reported 
in Wuhan, China on December 31, 2019, Taiwan confirms its first 
COVID- 19 case on January 22, 2020 in Taiwan. Taiwan Center of 
Disease Control (TCDC) has implemented different levels of NPIs 
since the inception of COVID- 19 pandemic. Individuals must wear 
facemasks in public transportations, healthcare facilities, and in-
door public space. Physical distancing was also strictly requested 
at restaurants and populated public venues. Moreover, Taiwanese 
governments strictly executed international border control by re-
questing all arriving passengers a 14- day compulsory quarantine 
with active surveillance on respiratory symptoms and body tem-
perature. After adopting these NPIs, TCDC observed a decline in 
positivity rates of influenza virus— an enveloped virus as SARS- CoV- 
2— declined from 375 cases in January 2020 to zero after March 
2020.11 A similar epidemiological change was also reported during 
the 2003 SARS- CoV epidemic in Taiwan where the number of diag-
nosed RTIs plummeted after the introduction of NPIs from January 
2003 to April 2003.11 Increasing facemask use, awareness of per-
sonal hygiene screening seeking behavior was observed during the 
2003 SARS- CoV epidemic in Hong Kong.12 Despite the observed 
decline of influenza infection during SARS and COVID- 19 epidem-
ics, little is known about the epidemiological impact of COVID- 19- 
related NPIs on the positivity rates of non- COVID- 19 RVs (NCRVs) 
(eg, influenza virus, sCoV, and EnV). Whether test positivity rates of 
enveloped and non- enveloped viruses vary by NPIs remains uncer-
tain. To understand the potential impacts of NPIs on the incidence 
of NCRVs, we examined the change in positivity rates during the 
COVID- 19 pandemic in Taiwan.
2  | METHODS
2.1 | Study design and patient recruitment
We presented a retrospective cross- sectional study using hospital- 
based surveillance data from Taipei Veterans General Hospital 
(TVGH), one of the biggest medical centers in Taiwan. We exam-
ined medical records on patients presenting respiratory symptoms 
from January 2019 to May 2020, defining two periods as pre- COVID 
(January 2019 to December 2019) and post- COVID (January 2020 
to May 2020). The study was approved by the institutional review 
board of TVGH (reference number: 2019- 06- 022CC).
2.2 | Respiratory examinations
Patients who presented respiratory symptoms were queried for 
traveling, occupation, contact, and cluster (TOCC) history followed 
by physical examinations and chest radiogram. One set of naso-
pharyngeal swab sample was collected from patients and sent to a 
centralized Biosafety Level 2 laboratory for multiplex reverse tran-
scription polymerase chain reaction (RT- PCR)- based assays. The RT- 
PCR assays were run by the Luminex xTAG® Respiratory Virus Panel 
(Luminex Molecular Diagnostics) or the BIOFIRE® FILMARRY® 
Respiratory Panel (BioFire Diagnostics). Types of RVs detectable by 
the two RT- PCR panels included AdV, influenza virus, PIV, hMPV, 
sCoV, RSV, and EnV/RhV (Appendix 1).
K E Y W O R D S
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2.3 | Levels of non- pharmaceutical interventions
Levels of NPIs in Taiwan were escalated with an increasing epidemic 
curve for COVID- 19 from January 2020. Here, we focused on the 
efficacy of interventions such as the use of personal protective 
equipment and physical distancing. The Central Epidemic Command 
Center enforced serial regulations on the use of personal protective 
equipment. The level 1 facemask regulation (F1) was adopted on 
January 28, 2020, when the first imported COVID- 19 case was con-
firmed in Taiwan. The government released two million facemasks 
into the market while restricting exports of medical facemasks; the 
general public were requested to wear facemask in crowded public 
space and at healthcare facilities. Meanwhile, a facemask rationing 
plan allowed Taiwanese to purchase up to two medical facemasks 
weekly per person with the registration of National Health Insurance 
cards. The level 2 facemask regulation (F2) was implemented on 
February 11, 2020, by which the government provided facemasks to 
public transportation drivers, and patients and caregivers in medical 
facilities on a daily basis. The level 3 facemask regulation (F3) was 
implemented on March 5, 2020, which allowed personal purchases 
for up to five facemasks per 14 days. The regulation also requested 
all passengers on public transportation wearing a facemask compul-
sorily with a fine at up to $2,000 USD on violators.
Taiwan officials announced physical distancing regulation (P) on 
March 25, 2020. Indoor activities involving over 100 participants, 
and outdoor activities involving over 500 participants were banned. 
The ban also discouraged unnecessary travels to reduce potential 
contacts. Most public activities were postponed or canceled after 
the announcement of the ban.
2.4 | Data analysis
Given the average incubation periods and serial intervals of NCRVs 
span from one to two weeks,13- 17 those who were tested more than 
once in any 14- day period were only counted as one test. Overall 
positivity rates of NCRVs each calendar month were calculated. 
The positivity rate of each NCRV was calculated to examine trend 
changes with various NPIs. We also categorized NCRVs into envel-
oped and non- enveloped viruses based on their virologic character-
istics. Positivity rates of these two virological groups were examined 
against different NPIs in a temporal sequence. Due to the limited 
sample size, we regrouped AdV, hMPV, hBoV, and PIV as other vi-
ruses. National surveillance data from TCDC on influenza virus infec-
tion were applied to examine data validity and representativeness.
2.5 | Statistical analysis
Descriptive statistics were applied to describe patient characteris-
tics. Categorical variables were analyzed by Pearson's chi- squared 
test. The significance level was set at 0.05. All analyses were con-
ducted using RStudio® statistical software (version: 1.3.959).
3  | RESULTS
Of all 9693 patients undergoing 12 127 multiplex RT- PCR tests, 4855 
were tested from January to December 2019 and 4838 from January 
to May 2020. Table 1 lists patient characteristics. The proportion 
of adult (aged 18 and above) patients were 84.4% (4099/4855) and 
94.0% (4546/4838) in pre- COVID and post- COVID period, respec-
tively. Compared with the same period in 2019, the total number of 
examined patients from January to May 2020 increased by 2.9 times 
(4838 versus 1664), with a 3.4- fold increase (4546 versus 1334) in 
adult visits and an 11% decrease (292 versus 330) in pediatric visits. 
The proportion of patients infected with more than one NCRVs dur-
ing pre- COVID period were higher than those visited during post- 
COVID period (3.7% versus 1.4%).
3.1 | Data validation
According to Taiwan National Infectious Disease Statistics System 
(TNIDSS), positivity rates of influenza virus in patients suspected 
with severe complicated influenza infection (defined as those with 
respiratory failure) were around 40% nationwide from January 2019 
to January 2020, followed by a steady decline from February 2020 
when NPIs were implemented to April 2020 when no cases of severe 
influenza infection were reported (Figure 1A). The trend of positiv-
ity rates of influenza in patients with severe respiratory tract infec-
tions at TVGH corresponded with TCDC’s national statistics during 
TA B L E  1   Characteristics of patients being tested for non- 




2020 Jan to May 
(Post- COVID)
Total number of RT- PCR 
tests
6012 6115
Number of repetitive 
tests (%)
1157 (19.2%) 1277 (20.1%)
Number of patients 4855 4838
Adult (%) 4098 (84.4%) 4546 (94.0%)
Pediatric (%) 757 (15.6%) 292 (6.0%)
Median Age 64 62
Adult patient 69 64
Pediatric patient 4 5
Number of patients 
infected with at least 
one NCRV (%)
1242 (25.6%) 696 (14.4%)
Number of patients 
infected with two or 
more NCRVs (%)
179 (3.7%) 66 (1.4%)
Number of patients 
under intensive care 
(%)
1079 (22.2%) 497 (10.3%)
Abbreviations: NRCV, Non- COVID- 19 Respiratory Virus; RT- PCR, 
reverse transcription polymerase chain reaction.
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pre- COVID and post- COVID periods, except for March 2020 given 
a relatively small sample size.11 Specifically, only one case suspected 
with severe complicated influenza infection was notified at TVGH 
in March 2020 with subsequent RT- PCR confirmation, resulting in a 
100% case positivity rate (Figure 1B).
3.2 | Overall positivity rates of NCRVs
The average positivity rate of NCRVs was 25.6% pre- COVID 
and 14.4% in post- COVID period. While the trend of NCRV in-
cidence remained steady in pre- COVID time, the rate peaked 
in January 2020 at 30.7% and declined gradually after Taiwan 
introduced NPIs as from 17.6% in February to 7.4% in May 2020 
(Figure 2A). Compared to the same period in 2019, the positiv-
ity rate in January 2020 was similar, but those from February to 
May 2020 were significantly lower (Ps<0.001) with a 17.2% av-
erage rate of reduction (Figure 3A). In adult patients, positivity 
rates from February 2020 to April 2020 reduced by 10.0% than 
the same months in 2019 (Figure 2B). We also observed a 3.3% 
rate reduction in May 2020 compared with that of May 2019 
(5.0% versus 8.3%, P =.06), albeit the presence of stringent 
NPIs (Figure 3B). Among pediatric patients, the average positiv-
ity rate of NCRVs in the study period was 56.3%. The positiv-
ity rates in both April 2020 and May 2020 were lower than the 
same months in 2019 following the implementation of F1- F3 and 
P phase of NPIs from Mach 2020 (Figure 2C). The average rate 
of reduction was 21.2%, reflecting a 48.6% alteration compared 
with the previous year (Figure 3C). When the Taiwanese govern-
ment leveled up facemask regulations from F1 to F3, a higher 
degree of positivity rate reduction was observed (See Appendix 
2 for detail).
3.3 | Positivity rates of enveloped and non- 
enveloped respiratory viruses
The influenza virus was the most predominant enveloped NCRVs 
in both adult (59.0%±22.7%) and pediatric (20.4%±14.3%) patients. 
The average positivity rate of enveloped NCRVs in adults in pre- 
COVID time was 14.0%- 17.6% (Figure 4A, red line). Such rate re-
mained stable (4.2%- 5.4%) exclusive of influenza virus (Figure 4A, 
blue line). After a combination of NPIs was implemented in January 
2020, the average positivity rate of non- influenza enveloped NCRVs 
in adults dropped to 3.6% in February- May 2020 (Figure 4A). A 
similar drop was observed in pediatric patients at 2.5% (Figure 4C). 
Adjusting for influenza virus infection, the positivity rates in both 
adult (2.5% versus 4.7%, P <.001) and pediatric patients (11.5% 
versus 26.4%, P <.001) reduced significantly after NPIs implemen-
tation (Figure 4A, C). Considering the potential effects of NPIs on 
non- enveloped NCRVs, the average positivity rates did not decline 
after the implementation of NPIs in Taiwan. In adults, compared 
with the pre- COVID period, a 0.8% increase in the average positiv-
ity rate was shown after initiation of the NPIs (5.9% versus 5.1%, 
P =.04) (Figure 4B). The positivity rate in children remained still re-
gardless of the implementation of NPIs (33.9% vs 33.8%, P =.69) 
(Figure 4D).
3.4 | Positivity rates of influenza virus
During the early phase of COVID- 19 epidemic in January 2020, the 
positivity rate of influenza in TVGH was comparable to that in 2019. 
As the government started strengthening the intervention meas-
ures, the positivity rate of adult patients declined from 16.6% in 
January 2020 to 3.3% in February 2020, and the overall positivity 
F I G U R E  1   Positivity Rates of severe complicated influenza infection reported either by Taiwan Center of Disease Control (TCDC) and 
Taipei Veterans General Hospital (TVGH). A, the black sold bars were the rates that TCDC reported in 2019 while the white bars were those 
in 2020. B, the black stripe bars were the rates that TVGH reported in 2019 while the white stripe bars were those in 2020. Rates of severe 
influenza virus infection were defined as the number of patients with respiratory failure and confirmed with influenza virus infection by 
reverse transcription polymerase chain reaction (RT- PCR) tests divided the total number of patients with respiratory failure and proceeded 
RT- PCR tests. *The outlier in March 2020 TVGH reported was 100% due to that there was only one patient suspected with influenza- 
related respiratory failure and confirmed by RT- PCR test
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rate from January to May in 2020 was significantly lower than that 
in 2019 (PT<0.001, Figure 5A). There was no influenza pediatric case 
observed after March 2020, and the overall positivity rate in 2020 
was significantly lower than that in 2019, which was similar to adult 
patients (PT=0.02, Figure 5E).
3.5 | Positivity rates of Enterovirus/Rhinovirus 
(EnV/RhV)
Regardless of NPIs, the positivity rates of EnV/RhV during the 
COVID- 19 epidemic did not reduce as compared to the previous 
year. In adults, the positivity rate of EnV/RhV remained above 6% in 
January and February 2020, and then gradually declined after March 
2020, but the monthly positivity rates remained similar to those of 
the previous year. The overall positivity rate of adult patients in 
2020 (4.9%) was not significantly different than that in 2019 (5.5%) 
(PT=0.48, Figure 5B). However, in pediatric patients, even with step-
wise NPIs, we did not observe a significant decline in the positivity 
rates of EnV/RhV during the epidemic period. On the other hand, the 
positivity rate increased above 30% since April 2020 and became 
significantly higher in May 2020 (44.1%) as compared to May 2019 
(23.7%) (P =.03, Figure 5F). The overall positivity rate of pediatric 
patients in 2020 (29.0%) was also not significantly different than that 
in 2019 (27.6%) (PT=0.97).
3.6 | Positivity rates of seasonal coronaviruses 
(sCoVs)
A high level of positivity rates was observed during the early phase 
of COVID- 19 epidemic since January 2020. In adult patients, the 
positivity rates of sCoVs in 2020 were higher than that in the same 
period in 2019, and the overall positivity rate in 2020 (1.6%) was 
F I G U R E  2   Number of patients and positivity rates of non- COVID respiratory viruses. A, All patients. B, Adult patients. C, Pediatric 
patients. SARS- CoV- 2 broke out in January 2020 and the Taiwanese government implemented various non- pharmaceutical interventions 
and infection control measures since February 2020. F1: level 1 facemask regulation, started on January 28. F2: level 2 facemask regulation, 
started on February 11. F3: level 3 facemask regulation, started on March 3. P: physical distancing, started on March 25
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higher than that in 2019 (1.0%). Although the positivity rates of 
2020 did not reach the statistically significant difference than 
those of 2019 in adult patients, the positivity rates during post- 
COVID period were still higher, especially from January to March 
(PT=0.17, Figure 5C). A peak of positivity rate was observed in pedi-
atric patients in January 2020; the overall positivity in 2020 (2.2%) 
was lower than that in 2019 (2.9%) (PT=0.80, Figure 5G). The posi-
tivity rates gradually declined with the implementation of higher 
levels of NPIs. Regarding subtypes of sCoVs in adults, sCoV- 229E 
was predominant during the pre- COVID period (20/41, 48.8%), 
followed by sCoV- OC43 (16/41, 39.0%), and sCoV- 229E (5/41, 
12.2%); in the post- COVID period, sCoV- OC43 became the most 
common subtype (35/71, 49.3%), followed by sCoV- 229E (18/71, 
25.4%), sCoV- NL63 (13/71, 18.3%), sCoV- HKU1 (4/71, 5.6%), and 
one case with an undetermined subtype. Considering pediatric pa-
tients, sCoV- OC43 was predominant during the pre- COVID period 
(14/25, 56.0%), followed by sCoV- 229E (5/25, 20.0%), sCoV- 229E 
(4/25, 16.0%), and sCoV- HKU1 (2/25, 8.0%); in the post- COVID 
period, sCoV- OC43 (3/7, 42.9%) and sCoV- NL63 (3/7, 42.9%) were 
both commonly detected in children, followed by sCoV- 229E (1/7, 
14.2%).
3.7 | Positivity rates of other respiratory viruses
With respect to all other NCRVs, compared with the same period in 
2019, the positivity rates in adult patients rose in January 2020 then 
gradually declined after March 2020, and the positivity rate in April 
2020 (1.2%) was significantly lower than that in April 2019 (5.5%) 
(P <.001). However, the overall positivity rate in 2020 (2.6%) was not 
significantly different than that in 2019 (3.4%) (PT=0.2, Figure 5D). 
Similarly, the positivity rate in pediatric patients in January 2020 was 
much higher than that of the previous year (23.1% to 5.0%, P <.001), 
but it declined since April 2020 to a value lower than that in 2019; 
and, the overall positivity rate in 2020 (12.9%) was significantly 
lower than of that in 2019 (24.3%) (PT<0.001, Figure 5H).
4  | DISCUSSION
Our study revealed a three- fold increase in the numbers of patients 
tested for NCRVs after the COVID- 19 outbreak in January 2020. 
Regarding types of NCRVs, influenza virus and enterovirus/rhino-
virus (EnV/RhV) were the most commonly reported enveloped and 
F I G U R E  3   Comparison of monthly 
positivity rates and rates of reduction 
of non- COVID- 19 respiratory viruses 
between January and May 2019 and 
January and May 2020, with reduction of 
positivity rates (the red spots). Percentage 
reduction of positivity rate was defined 
as positivity rate in 2020 subtracted that 
of 2019 and divided by positivity rate in 
2019. 3A, all patients. 3B, adult patients. 
3C, pediatric patients
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non- enveloped viruses regardless of the COVID- 19 pandemic. While 
the overall test positivity rate of NCRVs reduced after TCDC intro-
duced NPIs nationwide, such reduction was predominantly contrib-
uted by enveloped NCRVs. We did not observe the epidemiological 
impacts of NPIs on non- enveloped viruses in our hospital- based 
research.
Our findings have consolidated the protective effects of NPIs 
against enveloped viruses, including influenza viruses and seasonal 
coronaviruses. The results are in line with other studies of the effec-
tiveness of NPIs (ie, facemask usage and physical distance) on con-
trolling NCRVs in both the 2003 SARS outbreak in Taiwan and the 
current COVID- 19 pandemic.13,14 During the 2003 SARS outbreak, 
the positivity rates of NCRVs, especially influenza virus, dropped 
significantly after Taiwanese governments enacted NPIs such as 
universal facemask wearing and body temperature monitoring.18 
Recent studies have witnessed a reduction in the incidence of influ-
enza viruses after NPIs were adopted in Taiwan, Japan, New Zealand, 
and the United States. 14- 17 Regarding sub- population differences, 
we found that test positivity rates for influenza in adults dropped 
one month earlier than children (ie, February 2020 versus March 
2020). The temporal difference may be attributed to varied face-
mask availability between adults and children. Specifically, adult- size 
facemasks have been widely available since 28 January 2020, but 
child size ones were not available nationwide until 5 March 2020. 
More research in how and to what extent, availability of personal- 
protection equipment affects the mortality and mobility of sub- 
populations caused by both NCRVs and COVID- 19 are warranted.
Our results provide compelling evidence that current NPIs 
may have limited impacts on combating non- enveloped NCRVs. 
Contrary to existing findings from TNIDSS and the National Health 
Insurance Research Database, our hospital- based research showed 
that test positivity rates in both adults and children for EnV/RhV 
remained stagnant.19 The observed differentiated impacts of NPIs 
on enveloped and non- enveloped viruses can be explained by three 
factors. Firstly, non- enveloped viruses are more resistant to en-
vironmental challenges (eg heat, desiccation, and pH values) than 
enveloped viruses. The former are hydrophilic and with more ex-
tended survival periods than the latter with lipid bilayer, treated 
with alcohol- based disinfectants.20,21 Although Taiwan has ad-
opted alcohol- based fumigation to combat COVID- 19 transmission, 
the resistant nature of non- enveloped viruses make both entero-
viruses and rhinoviruses survive longer and thereby increase their 
likelihoods of transmission via person- to- person or contaminated 
surface.22- 27 Secondly, the protective effect of face mask may 
F I G U R E  4   Average positivity rates 
of enveloped and non- enveloped non- 
COVID- 19 respiratory viruses (NCRVs) 
in five different periods since 2019. A, 
Enveloped NCRVs in adult patients. B, 
Non- enveloped NCRVs in adult patients. 
C, Enveloped NCRVs in pediatric 
patients. D, Non- enveloped NCRVs in 
pediatric patients. Red line: data include 
influenza virus; blue line: positivity rates 
of enveloped NCRVs, pure influenza 
virus infection was excluded. Black 
arrow: sequential non- pharmaceutical 
interventions implemented by the 
Taiwanese government from January 28. 
*:P <.001; #:P =.04
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depend on types of viruses. Leung et al’s randomized control trial 
suggests that face mask is more effective in filtering out enveloped 
viruses (eg, influenza virus and sCoV) than non- enveloped viruses 
(eg, rhinovirus).28 This proposition can help to explain a rhinovirus 
outbreak in New Zealand, albeit its stringent interventions against 
COVID- 19.29 Thirdly, while Taiwan government requests all citizens 
to wear facemasks and improve hand hygiene, most venues only 
provide alcohol- based hand sanitizer, which had little viricidal ef-
fects against non- enveloped viruses. One can still carry and spread 
non- enveloped viruses after touching contaminated surfaces. 
Given alcohol- based disinfectants cannot kill non- enveloped vi-
ruses, chloride- and hydrogen peroxide- based products should be 
added into guidance for comprehensive infection control.30 While 
keeping increasing the public awareness of hand hygiene against 
non- enveloped viruses, governments should apply a combination 
of disinfectants to infection control so that the negative conse-
quences of both the COVID- 19 and NCRVs pandemics can be fur-
ther mitigated.
One notable observation from our study was that the positivity 
rates of sCoVs in January- March 2020 were much higher than the 
same periods in 2019. Such increase in sCoVs positivity rate might 
be explained by co- incidental COVID- 19 outbreak. Nevertheless, 
the positivity rates declined as NPIs were gradually intensified. 
Studies have shown that facemask usage and physical distancing 
were effective in preventing the transmission of sCoVs..31 However, 
studies demonstrating the correlation between sCoV incidence and 
individual NPI remained scarce. Further studies are necessary to ad-
dress such issues in the post- COVID- 19 era.
Our study bears several limitations. Firstly, our research was con-
ducted in a medical center in northern Taiwan with a limited number 
of patients. Our results, particularly of pediatric patients, cannot be 
generalized to national epidemiological trends of viral infection in 
Taiwan. We urge more studies using multi- center primary data and 
follow- up with more pediatric patients to capture the real- world ep-
idemiological changes. Secondly, RT- PCR tests were not commonly 
used in clinical assessment in the pre- COVID- 19 era. As the num-
ber of patients tested for NCRVs increased much compared with 
situations in 2019, our reported changes in trends might be over-
estimated. Thirdly, the reliability of specimen collection measures 
among different physicians was unknown, albeit guidance on the 
standard of care. Different ways in specimen collection could bias 
test positivity rates of NCRVs. Moreover, types of testable viruses 
are limited to the two multiplex RT- PCR systems, neither of which 
can distinguish enterovirus from rhinovirus infection. Subjected to 
such limitations, our test positivity rates of EnV/RhV can be biased 
and of limited use. Lastly, physical distancing, the universal wearing 
of masks, and hand hygiene have all been reported to be effective in 
reducing NCRVs transmission.16- 19 While non- pharmaceutical inter-
ventions might have had synergistic effects to prevent transmission 
of NCRVs, the size and extent of effectiveness should be carefully 
examined through a systemic approach. We could not calculate the 
individual effectiveness of every NPI that the Taiwanese government 
F I G U R E  5   Positivity rates of influenza virus, enterovirus/rhinovirus, seasonal coronavirus, and other viruses. A, B, C, and D, Adult 
patients; E, F, G, and H, Pediatric patients. Due to limited patients in adenovirus, parainfluenza virus, human metapneumovirus, human 
bocavirus, and respiratory syncytial virus, we categorized these viruses as “other viruses” in this study. PT: p values which compared overall 
positivity rates of four different non- COVID respiratory viruses in January 2020 to May 2020 with those of the same period in 2019
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implanted. Factors that potentially confound or interact with each 
NPI on the incidence of NCRVs should be investigated carefully in 
future studies applying mathematical modeling or causative designs.
5  | CONCLUSION
Non- pharmaceutical interventions play essential roles in preventing 
respiratory virus transmission. Comprising facemask wearing, physi-
cal distancing and alcohol- based sanitizers and disinfectants, cur-
rent public health interventions may not be sufficient to mitigate the 
spread of non- enveloped viruses. When such outbreaks threaten 
healthcare capacity, health authorities may consider hydrogen per-
oxide or chloride- based disinfectants as additional preventative 
strategies in the post- COVID- 19 era.
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